Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
Urological Institute of NE New York
mi
from
Albany, NY
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
Urological Institute of NE New York
mi
from
Albany, NY
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
AMP of NY
mi
from
Oneida, NY
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
AMP of NY
mi
from
Oneida, NY
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
AMP of NY
mi
from
Syracuse, NY
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
AMP of NY
mi
from
Syracuse, NY
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
Carolina Clinical Trials
mi
from
Concord, NC
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
Carolina Clinical Trials
mi
from
Concord, NC
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
The Urology Group
mi
from
Cincinnati, OH
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
The Urology Group
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
UCSEPA
mi
from
Bala Cynwyd, PA
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
UCSEPA
mi
from
Bala Cynwyd, PA
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
The West Clinic, PC
mi
from
Memphis, TN
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
The West Clinic, PC
mi
from
Memphis, TN
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
Urology of Virginia, PLLC
mi
from
Virginia Beach, VA
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
Urology of Virginia, PLLC
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
Seattle Cancer Care Alliance / University of Washington
mi
from
Seattle, WA
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
Seattle Cancer Care Alliance / University of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated:  2/5/2016
University of Colorado Cancer Center
mi
from
Aurora, CO
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy
Status: Enrolling
Updated: 2/5/2016
University of Colorado Cancer Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Phase I/II Trial to Establish the Safety and Preliminary Efficacy of the Combination of Docetaxel, Prednisone, and SOM 230 (Pasireotide) in Metastatic Castrate Resistant Prostate Cancer (CRPC).
Status: Enrolling
Updated:  2/8/2016
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Phase I/II Trial to Establish the Safety and Preliminary Efficacy of the Combination of Docetaxel, Prednisone, and SOM 230 (Pasireotide) in Metastatic Castrate Resistant Prostate Cancer (CRPC).
Status: Enrolling
Updated: 2/8/2016
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
M D Anderson Cancer Center
mi
from
Houston, TX
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
Audie L Murphy Veterans Affairs Hospital
mi
from
San Antonio, TX
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
Audie L Murphy Veterans Affairs Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
Cancer Therapy and Research Center
mi
from
San Antonio, TX
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
Cancer Therapy and Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
University Hospital
mi
from
San Antonio, TX
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
University Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel
Cabazitaxel With BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer Following Treatment With Docetaxel: Phase II Study With Safety Lead-in Cohort
Status: Enrolling
Updated:  2/10/2016
Florida Cancer Specialists South
mi
from
Ft. Myers, FL
Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel
Cabazitaxel With BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer Following Treatment With Docetaxel: Phase II Study With Safety Lead-in Cohort
Status: Enrolling
Updated: 2/10/2016
Florida Cancer Specialists South
mi
from
Ft. Myers, FL
Click here to add this to my saved trials
Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel
Cabazitaxel With BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer Following Treatment With Docetaxel: Phase II Study With Safety Lead-in Cohort
Status: Enrolling
Updated:  2/10/2016
Nebraska Methodist Hospital
mi
from
Omaha, NE
Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel
Cabazitaxel With BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer Following Treatment With Docetaxel: Phase II Study With Safety Lead-in Cohort
Status: Enrolling
Updated: 2/10/2016
Nebraska Methodist Hospital
mi
from
Omaha, NE
Click here to add this to my saved trials
Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel
Cabazitaxel With BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer Following Treatment With Docetaxel: Phase II Study With Safety Lead-in Cohort
Status: Enrolling
Updated:  2/10/2016
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel
Cabazitaxel With BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer Following Treatment With Docetaxel: Phase II Study With Safety Lead-in Cohort
Status: Enrolling
Updated: 2/10/2016
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Pilot Study of NanoKnife for Ablation of Prostate Cancer in Low Risk Patients
A Pilot Study in Human Subjects Evaluating the Use of the NanoKnife System for Ablation of Prostate Cancer Tissue in a Low Risk Patient Population
Status: Enrolling
Updated:  2/10/2016
Duke University
mi
from
Durham, NC
Pilot Study of NanoKnife for Ablation of Prostate Cancer in Low Risk Patients
A Pilot Study in Human Subjects Evaluating the Use of the NanoKnife System for Ablation of Prostate Cancer Tissue in a Low Risk Patient Population
Status: Enrolling
Updated: 2/10/2016
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide
Randomized, Controlled Study of an Exercise Intervention Program for Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Either Abiraterone or Enzalutamide
Status: Enrolling
Updated:  2/10/2016
Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide
Randomized, Controlled Study of an Exercise Intervention Program for Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Either Abiraterone or Enzalutamide
Status: Enrolling
Updated: 2/10/2016
Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery
A Pilot Phase I Open Label Study of Cu-64-TP3805 PET Imaging for Detection of Prostate Cancer in Men Undergoing Radical Prostatectomy
Status: Enrolling
Updated:  2/10/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery
A Pilot Phase I Open Label Study of Cu-64-TP3805 PET Imaging for Detection of Prostate Cancer in Men Undergoing Radical Prostatectomy
Status: Enrolling
Updated: 2/10/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
Phase 2/3 Study of Dose-escalated External Beam Radiation Therapy With or Without Chemotherapy for High Risk Adenocarcinoma of the Prostate
Status: Enrolling
Updated:  2/11/2016
CDH Proton Center
mi
from
Warrenville, IL
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
Phase 2/3 Study of Dose-escalated External Beam Radiation Therapy With or Without Chemotherapy for High Risk Adenocarcinoma of the Prostate
Status: Enrolling
Updated: 2/11/2016
CDH Proton Center
mi
from
Warrenville, IL
Click here to add this to my saved trials
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
Phase 2/3 Study of Dose-escalated External Beam Radiation Therapy With or Without Chemotherapy for High Risk Adenocarcinoma of the Prostate
Status: Enrolling
Updated:  2/11/2016
ProCure Proton Therapy Center
mi
from
Oklahoma City, OK
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
Phase 2/3 Study of Dose-escalated External Beam Radiation Therapy With or Without Chemotherapy for High Risk Adenocarcinoma of the Prostate
Status: Enrolling
Updated: 2/11/2016
ProCure Proton Therapy Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
Phase 2/3 Study of Dose-escalated External Beam Radiation Therapy With or Without Chemotherapy for High Risk Adenocarcinoma of the Prostate
Status: Enrolling
Updated:  2/11/2016
Hampton University Proton Therapy Institute
mi
from
Hampton, VA
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
Phase 2/3 Study of Dose-escalated External Beam Radiation Therapy With or Without Chemotherapy for High Risk Adenocarcinoma of the Prostate
Status: Enrolling
Updated: 2/11/2016
Hampton University Proton Therapy Institute
mi
from
Hampton, VA
Click here to add this to my saved trials
Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer
Phase I/II Study of Neoadjuvant Weekly Docetaxel and Mitoxantrone Prior to Prostatectomy in Patients With High Risk Localized Prostate Cancer
Status: Enrolling
Updated:  2/11/2016
OHSU Knight Cancer Institute
mi
from
Portland, OR
Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer
Phase I/II Study of Neoadjuvant Weekly Docetaxel and Mitoxantrone Prior to Prostatectomy in Patients With High Risk Localized Prostate Cancer
Status: Enrolling
Updated: 2/11/2016
OHSU Knight Cancer Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer
Phase I/II Study of Neoadjuvant Weekly Docetaxel and Mitoxantrone Prior to Prostatectomy in Patients With High Risk Localized Prostate Cancer
Status: Enrolling
Updated:  2/11/2016
Portland VA Medical Center
mi
from
Portland, OR
Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer
Phase I/II Study of Neoadjuvant Weekly Docetaxel and Mitoxantrone Prior to Prostatectomy in Patients With High Risk Localized Prostate Cancer
Status: Enrolling
Updated: 2/11/2016
Portland VA Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers
Pilot Study of the Role of 11-dh-TXB2 in Prostate Cancer Screening and Diagnosis
Status: Enrolling
Updated:  2/12/2016
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers
Pilot Study of the Role of 11-dh-TXB2 in Prostate Cancer Screening and Diagnosis
Status: Enrolling
Updated: 2/12/2016
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer
Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  2/16/2016
Queen's Medical Center
mi
from
Honolulu, HI
Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer
Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 2/16/2016
Queen's Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Randomized Trial of Suicide Gene Therapy and Prostate Cancer
A Randomized, Controlled Trial of Replication-Competent Adenovirus-Mediated Suicide Gene Therapy in Combination With IMRT Versus IMRT Alone for the Treatment of Newly-Diagnosed Prostate Cancer With an Intermediate Risk Profile
Status: Enrolling
Updated:  2/18/2016
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Randomized Trial of Suicide Gene Therapy and Prostate Cancer
A Randomized, Controlled Trial of Replication-Competent Adenovirus-Mediated Suicide Gene Therapy in Combination With IMRT Versus IMRT Alone for the Treatment of Newly-Diagnosed Prostate Cancer With an Intermediate Risk Profile
Status: Enrolling
Updated: 2/18/2016
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Randomized Trial of Suicide Gene Therapy and Prostate Cancer
A Randomized, Controlled Trial of Replication-Competent Adenovirus-Mediated Suicide Gene Therapy in Combination With IMRT Versus IMRT Alone for the Treatment of Newly-Diagnosed Prostate Cancer With an Intermediate Risk Profile
Status: Enrolling
Updated:  2/18/2016
Henry Ford Health System
mi
from
Detroit, MI
Randomized Trial of Suicide Gene Therapy and Prostate Cancer
A Randomized, Controlled Trial of Replication-Competent Adenovirus-Mediated Suicide Gene Therapy in Combination With IMRT Versus IMRT Alone for the Treatment of Newly-Diagnosed Prostate Cancer With an Intermediate Risk Profile
Status: Enrolling
Updated: 2/18/2016
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Northeast Georgia Medical Center
mi
from
Gainesville, GA
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Northeast Georgia Medical Center
mi
from
Gainesville, GA
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
mi
from
Savannah, GA
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
mi
from
Savannah, GA
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Veterans Affairs Medical Center - Hines
mi
from
Hines, IL
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Veterans Affairs Medical Center - Hines
mi
from
Hines, IL
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Swedish-American Regional Cancer Center
mi
from
Rockford, IL
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Swedish-American Regional Cancer Center
mi
from
Rockford, IL
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Hematology Oncology Associates of the Quad Cities
mi
from
Bettendorf, IA
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Hematology Oncology Associates of the Quad Cities
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Genesis Regional Cancer Center at Genesis Medical Center
mi
from
Davenport, IA
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Genesis Regional Cancer Center at Genesis Medical Center
mi
from
Davenport, IA
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
University of Mississippi Cancer Clinic
mi
from
Jackson, MS
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
University of Mississippi Cancer Clinic
mi
from
Jackson, MS
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
CCOP - Montana Cancer Consortium
mi
from
Billings, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
CCOP - Montana Cancer Consortium
mi
from
Billings, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Hematology-Oncology Centers of the Northern Rockies - Billings
mi
from
Billings, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Hematology-Oncology Centers of the Northern Rockies - Billings
mi
from
Billings, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Northern Rockies Radiation Oncology Center
mi
from
Billings, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Northern Rockies Radiation Oncology Center
mi
from
Billings, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
St. Vincent Healthcare Cancer Care Services
mi
from
Billings, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
St. Vincent Healthcare Cancer Care Services
mi
from
Billings, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Billings Clinic - Downtown
mi
from
Billings, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Billings Clinic - Downtown
mi
from
Billings, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Bozeman Deaconess Cancer Center
mi
from
Bozeman, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Bozeman Deaconess Cancer Center
mi
from
Bozeman, MT
Click here to add this to my saved trials